{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:02:27Z","timestamp":1768557747959,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1007\/s11910-001-0030-x","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T11:02:52Z","timestamp":1180695772000},"page":"271-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Infection and the etiology and pathogenesis of multiple sclerosis"],"prefix":"10.1007","volume":"1","author":[{"given":"Israel","family":"Steiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puiu","family":"Nisipianu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzhak","family":"Wirguin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"30_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1054\/mehy.1998.0835","volume":"51","author":"I Steiner","year":"2000","unstructured":"Steiner I, Wirguin I: Multiple sclerosis-in need of critical reappraisal. Med Hypoth 2000, 51:99\u2013106. A critical review of the immunologic hypothesis of multiple sclerosis.","journal-title":"Med Hypoth"},{"key":"30_CR2","first-page":"522","volume":"122","author":"GA Schumacher","year":"1965","unstructured":"Schumacher GA, Beebe G, Kubler RF, et al.: Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965, 122:522\u2013568.","journal-title":"Ann NY Acad Sci"},{"key":"30_CR3","first-page":"287","volume":"12","author":"P Marie","year":"1884","unstructured":"Marie P: Sclerose en plaques et maladies infectieuses. Prog Med 1884, 12:287\u2013289.","journal-title":"Prog Med"},{"key":"30_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, et al.: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000, 47:707\u2013717. A new look at multiple sclerosis (MS) pathology supporting the nonuniformity of the condition and the concept that MS is a syndrome.","journal-title":"Ann Neurol."},{"key":"30_CR5","first-page":"5","volume-title":"Multiple Sclerosis","author":"GC Ebers","year":"1998","unstructured":"Ebers GC, Sadovnick AD: Epidemiology. In Multiple Sclerosis. Edited by Paty DW, Ebers GC. Philadelphia: FA Davis; 1998:5\u201328. An up-to-date summary covering this topic."},{"key":"30_CR6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.6.4.382","volume":"6","author":"JF Kurtzke","year":"1993","unstructured":"Kurtzke JF: Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993, 6:382\u2013427.","journal-title":"Clin Microbiol Rev"},{"key":"30_CR7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1542\/peds.59.4.505","volume":"59","author":"JF Modlin","year":"1977","unstructured":"Modlin JF, Jabbour JT, Witte JJ, Halsey NA: Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics 1977, 59:505\u2013512.","journal-title":"Pediatrics"},{"key":"30_CR8","first-page":"581","volume":"9","author":"L Girones","year":"1928","unstructured":"Girones L: Sobre la clinical de la escleroisis multiple. Rev Med Barcelona 1928, 9:581\u2013589.","journal-title":"Rev Med Barcelona"},{"key":"30_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1212\/WNL.42.3.577","volume":"42","author":"S Fredrikson","year":"1992","unstructured":"Fredrikson S, Michelsberg J, Hillert J, et al.: Conugal multiple sclerosis. Immunogenetic characterization and analysis of T- and B-cell reactivity to myelin protein. Neurology 1992, 42:577\u2013582.","journal-title":"Neurology"},{"key":"30_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/brain\/86.2.315","volume":"86","author":"K Schapira","year":"1963","unstructured":"Schapira K, Poskanzer DC, Miller H: Familial and conjugal multiple sclerosis. Brain 1963, 86:315\u2013332.","journal-title":"Brain"},{"key":"30_CR11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jnnp.48.9.859","volume":"48","author":"G Dean","year":"1985","unstructured":"Dean G, McDougall EI, Elian M: Multiple sclerosis in research workers studying swayback in lambs: an updated report. J Neurol Neurosurg Psychiatry 1985, 48:859\u2013865.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"30_CR12","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1002\/ana.410360715","volume":"36","author":"RT Johnson","year":"1994","unstructured":"Johnson RT: The virology of demyelinating diseases. Ann Neurol 1994, 36:S54-S60.","journal-title":"Ann Neurol"},{"key":"30_CR13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","volume":"43","author":"The IFNB Multiple Sclerosis Study Group","year":"1993","unstructured":"The IFNB Multiple Sclerosis Study Group.: Interferon beta 1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double blind, placebo-controlled trial. Neurology 1993, 43:655\u2013661.","journal-title":"Neurology"},{"key":"30_CR14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1212\/WNL.49.2.358","volume":"49","author":"RA Rudick","year":"1997","unstructured":"Rudick RA, Goodkin DE, Jacobs LD, et al.: Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 1997, 49:358\u2013363.","journal-title":"Neurology"},{"key":"30_CR15","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(05)61359-1","volume":"352","author":"PRISM (Prevention of Relapses and Disability by Interferon b-1a Subcutaneously in Multiple Sclerosis) Study Group","year":"1998","unstructured":"PRISM (Prevention of Relapses and Disability by Interferon b-1a Subcutaneously in Multiple Sclerosis) Study Group.: Randomized double blind placebo controlled study of interferon b-1a in relapsing\/remitting multiple sclerosis. Lancet 1998, 352:1498\u20131504.","journal-title":"Lancet"},{"key":"30_CR16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/13550289609146894","volume":"2","author":"A Gessain","year":"1996","unstructured":"Gessain A: Virological aspects of tropical spastic paraparesis\/ HTLV-I associated myelopathy and HTLV-I infection. J Neurovirol 1996, 2:299\u2013306.","journal-title":"J Neurovirol"},{"key":"30_CR17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1212\/WNL.39.6.825","volume":"39","author":"EA Operskalski","year":"1989","unstructured":"Operskalski EA, Visscher BR, Malmgren RM, Detels R: A case-control study of multiple sclerosis. Neurology 1989, 39:825\u2013829.","journal-title":"Neurology"},{"key":"30_CR18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.1996.tb00051.x","volume":"94","author":"N Zilber","year":"1996","unstructured":"Zilber N, Kahana E: Risk factors for multiple sclerosis: a casecontrol study in Israel. Acta Neurol Scand 1996, 94:395\u2013403.","journal-title":"Acta Neurol Scand"},{"key":"30_CR19","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1212\/WNL.54.12.2307","volume":"54","author":"RA Marrie","year":"2000","unstructured":"Marrie RA, Wolfson C, Sturkenboom MC, et al.: Multiple sclerosis and antecedent infections: a case-control study. Neurology 2000, 54:2307\u20132310.","journal-title":"Neurology"},{"key":"30_CR20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0140-6736(85)92801-6","volume":"1","author":"WA Sibley","year":"1985","unstructured":"Sibley WA, Bamford CR, Clark K: Clinical viral infections and multiple sclerosis. Lancet 1985, 1:1313\u20131315.","journal-title":"Lancet"},{"key":"30_CR21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/jnnp.64.6.736","volume":"64","author":"S Edwards","year":"1998","unstructured":"Edwards S, Zvartau M, Clarke H, et al.: Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998, 64:736\u2013741.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"30_CR22","doi-asserted-by":"crossref","unstructured":"Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC: Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand 1993, (suppl 161):34\u201342.","DOI":"10.1111\/j.1600-0404.1995.tb05854.x"},{"key":"30_CR23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/CMR.10.3.521","volume":"3","author":"DK Braun","year":"1997","unstructured":"Braun DK, Dominguez G, Pellett P: Human herpesvirus 6. Clin Microbiol Rev 1997, 3:521\u2013567.","journal-title":"Clin Microbiol Rev"},{"key":"30_CR24","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/jvi.70.2.1296-1300.1996","volume":"70","author":"J He","year":"1996","unstructured":"He J, McCarthy M, Zhou Y, et al.: Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1996, 70:1296\u20131300.","journal-title":"J Virol"},{"key":"30_CR25","doi-asserted-by":"publisher","first-page":"7440","DOI":"10.1073\/pnas.92.16.7440","volume":"92","author":"PB Challoner","year":"1995","unstructured":"Challoner PB, Smith KT, Parker JD, et al.: Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995, 92:7440\u20137444.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/0003-4819-116-2-103","volume":"116","author":"D Buchwald","year":"1992","unstructured":"Buchwald D, Cheney PR, Peterson DL, et al.: A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992, 116:103\u2013113.","journal-title":"Ann Intern Med"},{"key":"30_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/(SICI)1096-9071(199707)52:3<301::AID-JMV11>3.0.CO;2-L","volume":"52","author":"LJ Novoa","year":"1997","unstructured":"Novoa LJ, Nagra RM, Nakawatase T, et al.: Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult. J Med Virol 1997, 52:301\u2013308.","journal-title":"J Med Virol"},{"key":"30_CR28","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.45.11.2015","volume":"45","author":"IR Mackenzie","year":"1995","unstructured":"Mackenzie IR, Carrigan DR, Wiley CA: Chronic myelopathy associated with human herpesvirus-6. Neurology 1995, 45:2015\u20132017.","journal-title":"Neurology"},{"key":"30_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1136\/jnnp.56.8.917","volume":"56","author":"P Sola","year":"1993","unstructured":"Sola P, Merelli E, Marasca R, et al.: Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993, 56:917\u2013919.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"30_CR30","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm1297-1394","volume":"3","author":"SS Soldan","year":"1997","unstructured":"Soldan SS, Berti R, Salem N, et al.: Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997, 3:1394\u20131397. A combined serologic\/molecular analysis of possible human herpes virus-6 infection in multiple sclerosis patients.","journal-title":"Nat Med"},{"key":"30_CR31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/13550289509114021","volume":"1","author":"W Liedtke","year":"1995","unstructured":"Liedtke W, Malessa R, Faustmann PM, Eis-Hubinger AM: Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995, 1:253\u2013258.","journal-title":"J Neurovirol"},{"key":"30_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1386-6532(99)00084-0","volume":"16","author":"BM Blumberg","year":"2000","unstructured":"Blumberg BM, Mock DJ, Powers JM, et al.: The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J Clin Virol 2000, 16:159\u2013178. A provocative study and discussion on the possible role of human herpes virus-6 in multiple sclerosis.","journal-title":"J Clin Virol"},{"key":"30_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nm0598-537b","volume":"4","author":"AR Coates","year":"1998","unstructured":"Coates AR, Bell J: HHV-6 and multiple sclerosis. Nat Med 1998, 4:537\u2013538.","journal-title":"Nat Med"},{"key":"30_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-065X.1996.tb00915.x","volume":"152","author":"I Steiner","year":"1996","unstructured":"Steiner I: Human herpes viruses latent infection in the nervous system. Immunol Rev 1996, 152:157\u2013173.","journal-title":"Immunol Rev"},{"key":"30_CR35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.55.2.178","volume":"55","author":"K Wandinger","year":"2000","unstructured":"Wandinger K, Jabs W, Siekhaus A, et al.: Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000, 55:178\u2013184.","journal-title":"Neurology"},{"key":"30_CR36","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1212\/WNL.42.9.1798","volume":"42","author":"PF Bray","year":"1992","unstructured":"Bray PF, Luka J, Bray PF, et al.: Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992, 42:1798\u20131804.","journal-title":"Neurology"},{"key":"30_CR37","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1073\/pnas.93.11.5177","volume":"93","author":"R Lower","year":"1996","unstructured":"Lower R, Lower J, Kurth R: The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A 1996, 93:5177\u20135184.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR38","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.1073\/pnas.94.14.7583","volume":"94","author":"H Perron","year":"1997","unstructured":"Perron H, Garson JA, Bedin F, et al.: Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A 1997, 94:7583\u20137588. An important contribution to the concept that a retrovirus might be present in multiple sclerosis patients\u2019 nervous system at a higher percentage than in the normal population.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0140-6736(98)24001-3","volume":"351","author":"JA Garson","year":"1998","unstructured":"Garson JA, Tuke PW, Giraud P, et al.: Detection of virionassociated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 1998, 351:33.","journal-title":"Lancet"},{"key":"30_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0092-8674(00)80338-4","volume":"90","author":"B Conrad","year":"1997","unstructured":"Conrad B, Weissmahr RN, Boni J, et al.: A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997, 90:303\u2013313.","journal-title":"Cell"},{"key":"30_CR41","first-page":"S76","volume":"6","author":"S Haahr","year":"2000","unstructured":"Haahr S, Munch M: The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirus. J Neurovirol 2000, 6:S76-S79. Discussion on the possible combined action of more than one pathogen in inducing central nervous system damage in multiple sclerosis.","journal-title":"J Neurovirol"},{"key":"30_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF01702882","volume":"9","author":"S Israel","year":"1995","unstructured":"Israel S, Mendelovitz M, Honigman A: Transactivation of human T-cell leukemia virus type 1 by herpes simplex virus type 1. Virus Genes 1995, 9:269\u2013276.","journal-title":"Virus Genes"},{"key":"30_CR43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.50.2.571","volume":"50","author":"S Sriram","year":"1998","unstructured":"Sriram S, Mitchell W, Stratton C: Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology 1998, 50:571\u2013572.","journal-title":"Neurology"},{"key":"30_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/1531-8249(199907)46:1<6::AID-ANA4>3.0.CO;2-M","volume":"46","author":"S Sriram","year":"1999","unstructured":"Sriram S, Stratton CW, Yao SY, et al.: Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999, 46:6\u201314. A systematic analysis of multiple sclerosis patients for evidence of a bacterial infection by a group that has first raised the possibility of Chlamydia pneumoniae infection in multiple sclerosis.","journal-title":"Ann Neurol"},{"key":"30_CR45","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/1531-8249(200005)47:5<652::AID-ANA15>3.0.CO;2-5","volume":"47","author":"G Layh-Schmitt","year":"2000","unstructured":"Layh-Schmitt G, Bendl C, Hildt U, et al.: Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann Neurol 2000, 47:652\u2013655.","journal-title":"Ann Neurol"},{"key":"30_CR46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/WNL.54.1.265","volume":"54","author":"J Boman","year":"2000","unstructured":"Boman J, Roblin PM, Sundstrom P, et al.: Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology 2000, 54:265.","journal-title":"Neurology"},{"key":"30_CR47","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/1531-8249(200009)48:3<400::AID-ANA21>3.0.CO;2-O","volume":"48","author":"Z Ke","year":"2000","unstructured":"Ke Z, Lu F, Roblin P, et al.: Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis. Ann Neurol 2000, 48:400.","journal-title":"Ann Neurol"},{"key":"30_CR48","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000, 343:938\u2013952.","journal-title":"N Engl J Med"},{"key":"30_CR49","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/nm1297-1321","volume":"3","author":"L Steinman","year":"1997","unstructured":"Steinman L, Oldstone MB: More mayhem from molecular mimics. Nat Med 1997, 3:1321\u20131322.","journal-title":"Nat Med"},{"key":"30_CR50","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1084\/jem.189.8.1275","volume":"189","author":"PJ Ruiz","year":"1999","unstructured":"Ruiz PJ, Garren H, Hirschberg DL, et al.: Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis. J Exp Med 1999, 189:1275\u20131283. On the possible role of antigens of infective agents in modulating the immune response against nervous system constituents.","journal-title":"J Exp Med"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-001-0030-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0030-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:33:02Z","timestamp":1744165982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-001-0030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s11910-001-0030-x","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}